"We recently celebrated the 25th anniversary of the 340B Drug Pricing Program, signed into law by then-President George H.W. Bush. With strong bipartisan support, the law requires drug companies to discount their prices when they sell to clinics, hospitals and health centers that care for large...
"Six senators, including three Republicans, are asking GOP leadership to block a Trump administration rule that slashes funding for a federal drug discount program. The program, called 340B, requires drug companies give discounts to health-care organizations that serve high volumes of low-income patients. But a new rule from the...
"The 340B drug discount program was created in 1992 and requires drug companies to sell medications at a discount to hospitals that serve large numbers of low-income and rural patients. In Iowa and across America, 340B is part of the solution to high prescription drug...
"Now more than ever, we need to examine all approaches to solving the health care crisis for our vulnerable children, families and seniors in rural Oregon. With more than 600,000 living in rural areas across Oregon, we have to be acutely aware of how best...
"The Association of American Cancer Institutes (AACI) opposes the Centers for Medicare and Medicaid Services (CMS)’ Medicare Programs: Hospital Outpatient Prospective Payment Systems (OPPS) rule, released on November 1. The rule will cut hospital 340B reimbursement from average sales price (ASP) plus 6 percent to...
"Today, Reps. David B. McKinley, P.E., (WV-1) and Mike Thompson (CA-5) introduced H.R. 4392 to reverse a Centers for Medicare and Medicaid Services (CMS) rule cutting $1.6B for drugs purchased by certain hospitals covered under the 340B program. These cuts jeopardize care for millions by...
"The AHA joined by the Association of American Medical Colleges and America’s Essential Hospitals today filed a federal lawsuit to prevent the Centers for Medicare & Medicaid Services from reducing Medicare payments for hospital outpatient drugs under the 340B Drug Pricing Program by nearly 30%....
"Today there is much talk about the state of health care in America. Everything from repealing Obamacare to dealing with the opioid epidemic seems to be on everyone’s radars. But one thing that’s not being talked about is the proposed change to a vital drug...
"As President Donald Trump wields his executive power to roll back portions of Obamacare, a new lawsuit seeks to force his administration to detail why it delayed penalizing drug makers for overcharging for certain prescriptions. The suit, filed Friday by the nonprofit watchdog group Democracy Forward and shared...
